Structure

Physi-Chem Properties

Molecular Weight:  516.38
Volume:  563.844
LogP:  3.917
LogD:  3.695
LogS:  -4.434
# Rotatable Bonds:  8
TPSA:  86.99
# H-Bond Aceptor:  5
# H-Bond Donor:  3
# Rings:  4
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.287
Synthetic Accessibility Score:  5.143
Fsp3:  0.844
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.062
MDCK Permeability:  3.184807792422362e-05
Pgp-inhibitor:  0.791
Pgp-substrate:  0.004
Human Intestinal Absorption (HIA):  0.015
20% Bioavailability (F20%):  0.97
30% Bioavailability (F30%):  0.97

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.163
Plasma Protein Binding (PPB):  94.01019287109375%
Volume Distribution (VD):  1.224
Pgp-substrate:  1.6157957315444946%

ADMET: Metabolism

CYP1A2-inhibitor:  0.011
CYP1A2-substrate:  0.273
CYP2C19-inhibitor:  0.053
CYP2C19-substrate:  0.931
CYP2C9-inhibitor:  0.119
CYP2C9-substrate:  0.465
CYP2D6-inhibitor:  0.012
CYP2D6-substrate:  0.616
CYP3A4-inhibitor:  0.491
CYP3A4-substrate:  0.629

ADMET: Excretion

Clearance (CL):  3.022
Half-life (T1/2):  0.741

ADMET: Toxicity

hERG Blockers:  0.036
Human Hepatotoxicity (H-HT):  0.127
Drug-inuced Liver Injury (DILI):  0.019
AMES Toxicity:  0.024
Rat Oral Acute Toxicity:  0.124
Maximum Recommended Daily Dose:  0.912
Skin Sensitization:  0.702
Carcinogencity:  0.021
Eye Corrosion:  0.006
Eye Irritation:  0.284
Respiratory Toxicity:  0.96

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC474922

Natural Product ID:  NPC474922
Common Name*:   Colossolactone A
IUPAC Name:   [(3S,5R,10R,13R,14R,17R)-17-[(Z,2S)-3,7-dihydroxy-6-methylhept-5-en-2-yl]-3-hydroxy-4,4,13,14-tetramethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-10-yl]methyl acetate
Synonyms:  
Standard InCHIKey:  UBOFIPWTXMSWDI-ISGKCMTKSA-N
Standard InCHI:  InChI=1S/C32H52O5/c1-20(18-33)8-10-26(35)21(2)23-12-15-31(7)24-9-11-27-29(4,5)28(36)14-17-32(27,19-37-22(3)34)25(24)13-16-30(23,31)6/h8,21,23,26-28,33,35-36H,9-19H2,1-7H3/b20-8-/t21-,23+,26?,27-,28-,30+,31-,32-/m0/s1
SMILES:  CC(C1CCC2(C1(CCC3=C2CCC4C3(CCC(C4(C)C)O)COC(=O)C)C)C)C(CC=C(C)CO)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL487868
PubChem CID:   10118664
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO31039 Ganoderma colossum Species Ganodermataceae Eukaryota n.a. n.a. n.a. PMID[18547117]
NPO31039 Ganoderma colossum Species Ganodermataceae Eukaryota n.a. vietnamese n.a. PMID[18547117]
NPO31039 Ganoderma colossum Species Ganodermataceae Eukaryota n.a. Vietnamese n.a. PMID[19813754]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT202 Individual Protein Protease Human immunodeficiency virus 1 IC50 = 39.0 ug.mL-1 PMID[502713]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC474922 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9556 High Similarity NPC276103
0.9556 High Similarity NPC54248
0.9111 High Similarity NPC234335
0.9032 High Similarity NPC141401
0.8977 High Similarity NPC474970
0.8958 High Similarity NPC85742
0.8925 High Similarity NPC304899
0.8925 High Similarity NPC253115
0.8866 High Similarity NPC473543
0.8854 High Similarity NPC476471
0.8854 High Similarity NPC475344
0.8804 High Similarity NPC38232
0.8763 High Similarity NPC474124
0.8763 High Similarity NPC473523
0.875 High Similarity NPC475617
0.8737 High Similarity NPC247233
0.871 High Similarity NPC119562
0.871 High Similarity NPC279410
0.8696 High Similarity NPC477574
0.8696 High Similarity NPC177641
0.8696 High Similarity NPC26888
0.8681 High Similarity NPC246028
0.8646 High Similarity NPC208358
0.8632 High Similarity NPC475032
0.8632 High Similarity NPC475033
0.8632 High Similarity NPC320306
0.8602 High Similarity NPC214697
0.8602 High Similarity NPC27918
0.86 High Similarity NPC472218
0.86 High Similarity NPC472217
0.86 High Similarity NPC472219
0.8587 High Similarity NPC148414
0.8587 High Similarity NPC175628
0.8587 High Similarity NPC111585
0.8587 High Similarity NPC295668
0.8557 High Similarity NPC155974
0.8556 High Similarity NPC477668
0.8556 High Similarity NPC6391
0.8556 High Similarity NPC261266
0.8539 High Similarity NPC102048
0.8526 High Similarity NPC7124
0.8511 High Similarity NPC469406
0.8495 Intermediate Similarity NPC41239
0.8495 Intermediate Similarity NPC212948
0.8478 Intermediate Similarity NPC16265
0.8478 Intermediate Similarity NPC262858
0.8478 Intermediate Similarity NPC472240
0.8478 Intermediate Similarity NPC146554
0.8478 Intermediate Similarity NPC474889
0.8454 Intermediate Similarity NPC473510
0.8454 Intermediate Similarity NPC251680
0.8454 Intermediate Similarity NPC327431
0.8438 Intermediate Similarity NPC99726
0.8427 Intermediate Similarity NPC477667
0.8421 Intermediate Similarity NPC279974
0.8409 Intermediate Similarity NPC209620
0.8409 Intermediate Similarity NPC23852
0.8404 Intermediate Similarity NPC473678
0.8387 Intermediate Similarity NPC469400
0.8387 Intermediate Similarity NPC220216
0.8387 Intermediate Similarity NPC48732
0.8387 Intermediate Similarity NPC471896
0.8384 Intermediate Similarity NPC473694
0.8384 Intermediate Similarity NPC222153
0.8384 Intermediate Similarity NPC475623
0.8384 Intermediate Similarity NPC36688
0.8384 Intermediate Similarity NPC475334
0.837 Intermediate Similarity NPC470613
0.837 Intermediate Similarity NPC470612
0.837 Intermediate Similarity NPC242864
0.8367 Intermediate Similarity NPC295110
0.8367 Intermediate Similarity NPC247701
0.8367 Intermediate Similarity NPC25177
0.8367 Intermediate Similarity NPC222875
0.8367 Intermediate Similarity NPC268829
0.8365 Intermediate Similarity NPC472926
0.8352 Intermediate Similarity NPC168231
0.8351 Intermediate Similarity NPC102426
0.8351 Intermediate Similarity NPC119036
0.8351 Intermediate Similarity NPC300179
0.8351 Intermediate Similarity NPC218107
0.8333 Intermediate Similarity NPC299963
0.8333 Intermediate Similarity NPC120708
0.8333 Intermediate Similarity NPC190713
0.8333 Intermediate Similarity NPC173272
0.8333 Intermediate Similarity NPC88009
0.8317 Intermediate Similarity NPC475781
0.8316 Intermediate Similarity NPC476186
0.8316 Intermediate Similarity NPC472416
0.8316 Intermediate Similarity NPC472360
0.8315 Intermediate Similarity NPC256112
0.8315 Intermediate Similarity NPC101462
0.8315 Intermediate Similarity NPC87489
0.8315 Intermediate Similarity NPC50964
0.8315 Intermediate Similarity NPC202389
0.8315 Intermediate Similarity NPC472504
0.83 Intermediate Similarity NPC181104
0.83 Intermediate Similarity NPC475331
0.83 Intermediate Similarity NPC475335
0.83 Intermediate Similarity NPC80809
0.83 Intermediate Similarity NPC201144
0.83 Intermediate Similarity NPC152966
0.83 Intermediate Similarity NPC121518
0.83 Intermediate Similarity NPC103298
0.83 Intermediate Similarity NPC288502
0.8298 Intermediate Similarity NPC124374
0.8283 Intermediate Similarity NPC293753
0.8283 Intermediate Similarity NPC475558
0.8283 Intermediate Similarity NPC281702
0.8283 Intermediate Similarity NPC234892
0.8283 Intermediate Similarity NPC473788
0.828 Intermediate Similarity NPC314727
0.828 Intermediate Similarity NPC261320
0.828 Intermediate Similarity NPC473647
0.8276 Intermediate Similarity NPC275910
0.8265 Intermediate Similarity NPC161527
0.8265 Intermediate Similarity NPC307954
0.8265 Intermediate Similarity NPC477972
0.8265 Intermediate Similarity NPC219285
0.8265 Intermediate Similarity NPC230546
0.8265 Intermediate Similarity NPC477971
0.8265 Intermediate Similarity NPC20113
0.8265 Intermediate Similarity NPC477968
0.8265 Intermediate Similarity NPC228251
0.8261 Intermediate Similarity NPC159046
0.8261 Intermediate Similarity NPC233836
0.8261 Intermediate Similarity NPC187376
0.8261 Intermediate Similarity NPC245004
0.8247 Intermediate Similarity NPC261807
0.8247 Intermediate Similarity NPC210337
0.8242 Intermediate Similarity NPC266511
0.8242 Intermediate Similarity NPC35933
0.8229 Intermediate Similarity NPC48330
0.8229 Intermediate Similarity NPC69548
0.8229 Intermediate Similarity NPC476894
0.8229 Intermediate Similarity NPC184848
0.8218 Intermediate Similarity NPC119855
0.8218 Intermediate Similarity NPC278628
0.8218 Intermediate Similarity NPC220217
0.8218 Intermediate Similarity NPC60315
0.8218 Intermediate Similarity NPC470056
0.8218 Intermediate Similarity NPC231530
0.8218 Intermediate Similarity NPC470055
0.8211 Intermediate Similarity NPC476304
0.8211 Intermediate Similarity NPC99653
0.8211 Intermediate Similarity NPC26046
0.8202 Intermediate Similarity NPC142163
0.82 Intermediate Similarity NPC97487
0.82 Intermediate Similarity NPC160583
0.82 Intermediate Similarity NPC189588
0.82 Intermediate Similarity NPC10232
0.82 Intermediate Similarity NPC187302
0.82 Intermediate Similarity NPC196471
0.8191 Intermediate Similarity NPC78973
0.8191 Intermediate Similarity NPC123252
0.8191 Intermediate Similarity NPC219937
0.8191 Intermediate Similarity NPC194485
0.8191 Intermediate Similarity NPC53890
0.8191 Intermediate Similarity NPC473269
0.8182 Intermediate Similarity NPC235920
0.8182 Intermediate Similarity NPC143182
0.8182 Intermediate Similarity NPC153987
0.8182 Intermediate Similarity NPC96784
0.8182 Intermediate Similarity NPC28862
0.8182 Intermediate Similarity NPC47982
0.8182 Intermediate Similarity NPC30986
0.8182 Intermediate Similarity NPC81306
0.8182 Intermediate Similarity NPC109546
0.8182 Intermediate Similarity NPC84694
0.8182 Intermediate Similarity NPC289670
0.8182 Intermediate Similarity NPC209430
0.8182 Intermediate Similarity NPC44083
0.8172 Intermediate Similarity NPC280556
0.8172 Intermediate Similarity NPC160304
0.8172 Intermediate Similarity NPC474668
0.8163 Intermediate Similarity NPC48647
0.8163 Intermediate Similarity NPC275086
0.8163 Intermediate Similarity NPC477813
0.8163 Intermediate Similarity NPC470067
0.8163 Intermediate Similarity NPC470068
0.8163 Intermediate Similarity NPC470066
0.8163 Intermediate Similarity NPC325229
0.8163 Intermediate Similarity NPC92275
0.8161 Intermediate Similarity NPC214570
0.8155 Intermediate Similarity NPC284828
0.8155 Intermediate Similarity NPC472216
0.8155 Intermediate Similarity NPC173905
0.8155 Intermediate Similarity NPC5475
0.8152 Intermediate Similarity NPC293287
0.8152 Intermediate Similarity NPC152808
0.8152 Intermediate Similarity NPC55309
0.8152 Intermediate Similarity NPC28252
0.8144 Intermediate Similarity NPC475178
0.8144 Intermediate Similarity NPC284194
0.8144 Intermediate Similarity NPC42042
0.8144 Intermediate Similarity NPC471903
0.8144 Intermediate Similarity NPC328371
0.8144 Intermediate Similarity NPC471765
0.8144 Intermediate Similarity NPC221801
0.8144 Intermediate Similarity NPC211810

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC474922 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8454 Intermediate Similarity NPD7640 Approved
0.8454 Intermediate Similarity NPD7639 Approved
0.8351 Intermediate Similarity NPD7638 Approved
0.7835 Intermediate Similarity NPD6399 Phase 3
0.7745 Intermediate Similarity NPD7632 Discontinued
0.7732 Intermediate Similarity NPD7637 Suspended
0.7727 Intermediate Similarity NPD6942 Approved
0.7727 Intermediate Similarity NPD7339 Approved
0.7692 Intermediate Similarity NPD7525 Registered
0.7684 Intermediate Similarity NPD4751 Clinical (unspecified phase)
0.7634 Intermediate Similarity NPD6695 Phase 3
0.7553 Intermediate Similarity NPD7338 Clinical (unspecified phase)
0.7553 Intermediate Similarity NPD4786 Approved
0.7526 Intermediate Similarity NPD6051 Approved
0.75 Intermediate Similarity NPD7750 Discontinued
0.7444 Intermediate Similarity NPD3701 Clinical (unspecified phase)
0.74 Intermediate Similarity NPD7748 Approved
0.7391 Intermediate Similarity NPD6929 Approved
0.7374 Intermediate Similarity NPD8035 Phase 2
0.7374 Intermediate Similarity NPD8034 Phase 2
0.7368 Intermediate Similarity NPD8033 Approved
0.7358 Intermediate Similarity NPD6675 Approved
0.7358 Intermediate Similarity NPD6402 Approved
0.7358 Intermediate Similarity NPD5739 Approved
0.7358 Intermediate Similarity NPD7128 Approved
0.7347 Intermediate Similarity NPD5328 Approved
0.734 Intermediate Similarity NPD3667 Approved
0.7333 Intermediate Similarity NPD8264 Approved
0.7321 Intermediate Similarity NPD7115 Discovery
0.732 Intermediate Similarity NPD7524 Approved
0.7312 Intermediate Similarity NPD6930 Phase 2
0.7312 Intermediate Similarity NPD6931 Approved
0.73 Intermediate Similarity NPD5779 Approved
0.73 Intermediate Similarity NPD5778 Approved
0.7292 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.7282 Intermediate Similarity NPD4225 Approved
0.7281 Intermediate Similarity NPD8294 Approved
0.7281 Intermediate Similarity NPD8377 Approved
0.7257 Intermediate Similarity NPD7327 Approved
0.7257 Intermediate Similarity NPD7328 Approved
0.7222 Intermediate Similarity NPD7320 Approved
0.7222 Intermediate Similarity NPD6881 Approved
0.7222 Intermediate Similarity NPD6899 Approved
0.7217 Intermediate Similarity NPD8379 Approved
0.7217 Intermediate Similarity NPD8296 Approved
0.7217 Intermediate Similarity NPD8378 Approved
0.7217 Intermediate Similarity NPD8335 Approved
0.7217 Intermediate Similarity NPD8380 Approved
0.7216 Intermediate Similarity NPD3618 Phase 1
0.7204 Intermediate Similarity NPD7645 Phase 2
0.72 Intermediate Similarity NPD7515 Phase 2
0.72 Intermediate Similarity NPD6079 Approved
0.7196 Intermediate Similarity NPD6008 Approved
0.7193 Intermediate Similarity NPD7516 Approved
0.7184 Intermediate Similarity NPD6083 Phase 2
0.7184 Intermediate Similarity NPD6084 Phase 2
0.7184 Intermediate Similarity NPD7902 Approved
0.7182 Intermediate Similarity NPD8130 Phase 1
0.7174 Intermediate Similarity NPD5776 Phase 2
0.7174 Intermediate Similarity NPD6925 Approved
0.7157 Intermediate Similarity NPD5695 Phase 3
0.7156 Intermediate Similarity NPD6373 Approved
0.7156 Intermediate Similarity NPD6372 Approved
0.713 Intermediate Similarity NPD5697 Approved
0.713 Intermediate Similarity NPD5701 Approved
0.7128 Intermediate Similarity NPD4748 Discontinued
0.7128 Intermediate Similarity NPD7514 Phase 3
0.7117 Intermediate Similarity NPD8297 Approved
0.7097 Intermediate Similarity NPD7145 Approved
0.7091 Intermediate Similarity NPD7290 Approved
0.7091 Intermediate Similarity NPD6883 Approved
0.7091 Intermediate Similarity NPD7102 Approved
0.7071 Intermediate Similarity NPD6672 Approved
0.7071 Intermediate Similarity NPD5737 Approved
0.7069 Intermediate Similarity NPD7503 Approved
0.7064 Intermediate Similarity NPD6011 Approved
0.7054 Intermediate Similarity NPD4632 Approved
0.7053 Intermediate Similarity NPD6902 Approved
0.7041 Intermediate Similarity NPD5330 Approved
0.7041 Intermediate Similarity NPD6409 Approved
0.7041 Intermediate Similarity NPD6684 Approved
0.7041 Intermediate Similarity NPD7146 Approved
0.7041 Intermediate Similarity NPD7521 Approved
0.7041 Intermediate Similarity NPD7334 Approved
0.7033 Intermediate Similarity NPD6924 Approved
0.7033 Intermediate Similarity NPD6926 Approved
0.703 Intermediate Similarity NPD7087 Discontinued
0.703 Intermediate Similarity NPD6411 Approved
0.7027 Intermediate Similarity NPD6847 Approved
0.7027 Intermediate Similarity NPD6650 Approved
0.7027 Intermediate Similarity NPD6649 Approved
0.7027 Intermediate Similarity NPD6617 Approved
0.7027 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7027 Intermediate Similarity NPD6869 Approved
0.7 Intermediate Similarity NPD6014 Approved
0.7 Intermediate Similarity NPD6012 Approved
0.7 Intermediate Similarity NPD6013 Approved
0.6981 Remote Similarity NPD5344 Discontinued
0.6964 Remote Similarity NPD6882 Approved
0.6964 Remote Similarity NPD6053 Discontinued
0.6961 Remote Similarity NPD4202 Approved
0.6947 Remote Similarity NPD7332 Phase 2
0.6939 Remote Similarity NPD6893 Approved
0.6923 Remote Similarity NPD5220 Clinical (unspecified phase)
0.6923 Remote Similarity NPD4697 Phase 3
0.6923 Remote Similarity NPD5222 Approved
0.6923 Remote Similarity NPD5221 Approved
0.6916 Remote Similarity NPD5211 Phase 2
0.6915 Remote Similarity NPD6115 Approved
0.6915 Remote Similarity NPD5784 Clinical (unspecified phase)
0.6915 Remote Similarity NPD6114 Approved
0.6915 Remote Similarity NPD6697 Approved
0.6915 Remote Similarity NPD6118 Approved
0.6907 Remote Similarity NPD5362 Discontinued
0.69 Remote Similarity NPD7513 Clinical (unspecified phase)
0.69 Remote Similarity NPD6903 Approved
0.6893 Remote Similarity NPD7900 Approved
0.6893 Remote Similarity NPD7901 Clinical (unspecified phase)
0.6882 Remote Similarity NPD6933 Approved
0.687 Remote Similarity NPD6009 Approved
0.6869 Remote Similarity NPD5279 Phase 3
0.6857 Remote Similarity NPD4755 Approved
0.6857 Remote Similarity NPD5173 Approved
0.6848 Remote Similarity NPD4785 Approved
0.6848 Remote Similarity NPD4784 Approved
0.6847 Remote Similarity NPD4061 Clinical (unspecified phase)
0.6847 Remote Similarity NPD8132 Clinical (unspecified phase)
0.6838 Remote Similarity NPD6319 Approved
0.6837 Remote Similarity NPD3666 Approved
0.6837 Remote Similarity NPD3668 Phase 3
0.6837 Remote Similarity NPD3133 Approved
0.6837 Remote Similarity NPD6400 Clinical (unspecified phase)
0.6837 Remote Similarity NPD3665 Phase 1
0.6833 Remote Similarity NPD7507 Approved
0.6832 Remote Similarity NPD5764 Clinical (unspecified phase)
0.6832 Remote Similarity NPD6101 Approved
0.6827 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6818 Remote Similarity NPD6412 Phase 2
0.6813 Remote Similarity NPD7151 Approved
0.6813 Remote Similarity NPD7152 Approved
0.6813 Remote Similarity NPD4243 Approved
0.6813 Remote Similarity NPD7150 Approved
0.6809 Remote Similarity NPD6932 Approved
0.6807 Remote Similarity NPD7604 Phase 2
0.68 Remote Similarity NPD4250 Approved
0.68 Remote Similarity NPD4251 Approved
0.6792 Remote Similarity NPD5696 Approved
0.6789 Remote Similarity NPD5141 Approved
0.6783 Remote Similarity NPD6868 Approved
0.678 Remote Similarity NPD5983 Phase 2
0.6778 Remote Similarity NPD6922 Approved
0.6778 Remote Similarity NPD6923 Approved
0.6777 Remote Similarity NPD8293 Discontinued
0.6771 Remote Similarity NPD5790 Clinical (unspecified phase)
0.6757 Remote Similarity NPD6686 Approved
0.675 Remote Similarity NPD7492 Approved
0.6737 Remote Similarity NPD7322 Clinical (unspecified phase)
0.6735 Remote Similarity NPD5332 Approved
0.6735 Remote Similarity NPD5331 Approved
0.6729 Remote Similarity NPD4700 Approved
0.6729 Remote Similarity NPD5286 Approved
0.6729 Remote Similarity NPD4696 Approved
0.6729 Remote Similarity NPD6648 Approved
0.6729 Remote Similarity NPD5285 Approved
0.6721 Remote Similarity NPD7736 Approved
0.6703 Remote Similarity NPD7144 Approved
0.6703 Remote Similarity NPD7143 Approved
0.6702 Remote Similarity NPD6117 Approved
0.6701 Remote Similarity NPD4790 Discontinued
0.6701 Remote Similarity NPD6898 Phase 1
0.67 Remote Similarity NPD4249 Approved
0.67 Remote Similarity NPD6098 Approved
0.6699 Remote Similarity NPD5281 Approved
0.6699 Remote Similarity NPD6050 Approved
0.6699 Remote Similarity NPD5284 Approved
0.6695 Remote Similarity NPD6059 Approved
0.6695 Remote Similarity NPD6054 Approved
0.6694 Remote Similarity NPD6616 Approved
0.6694 Remote Similarity NPD6336 Discontinued
0.6667 Remote Similarity NPD4753 Phase 2
0.6667 Remote Similarity NPD6904 Approved
0.6667 Remote Similarity NPD6080 Approved
0.6667 Remote Similarity NPD6335 Approved
0.6667 Remote Similarity NPD7319 Approved
0.6667 Remote Similarity NPD5223 Approved
0.6667 Remote Similarity NPD4195 Approved
0.6667 Remote Similarity NPD6683 Phase 2
0.6667 Remote Similarity NPD6673 Approved
0.6639 Remote Similarity NPD7078 Approved
0.6638 Remote Similarity NPD6274 Approved
0.6637 Remote Similarity NPD5955 Clinical (unspecified phase)
0.6632 Remote Similarity NPD6116 Phase 1
0.661 Remote Similarity NPD7101 Approved
0.661 Remote Similarity NPD7100 Approved
0.6609 Remote Similarity NPD8133 Approved
0.6606 Remote Similarity NPD5225 Approved
0.6606 Remote Similarity NPD5224 Approved
0.6606 Remote Similarity NPD5226 Approved
0.6606 Remote Similarity NPD4633 Approved
0.6602 Remote Similarity NPD5692 Phase 3

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data